DCM
SGMO

Dupont Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Dupont Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,907
Closed -$373K – 1649
2020
Q4 		$373K Sell
23,907
-6,248
-21% -$73.2K 0.01% 958
2020
Q3 		$285K Sell
30,155
-2,020
-6% -$21.8K 0.01% 992
2020
Q2 		$288K Sell
32,175
-14,284
-31% -$133K 0.01% 984
2020
Q1 		$296K Hold
46,459
– – 0.01% 866
2019
Q4 		$389K Buy
46,459
+14,615
+46% +$134K 0.01% 958
2019
Q3 		$288K Buy
+31,844
New +$357K 0.01% 1016
2018
Q2 		– Sell
-13,583
Closed -$258K – 1030
2018
Q1 		$258K Buy
+13,583
New +$290K 0.01% 785

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dupont Capital Management's SGMO Position: Q1 2021 in Review

Dupont Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2021, closing a stake of 23,907 shares — an estimated $373K sold.

Dupont Capital Management first reported a position in SGMO in Q1 2018 and held it in 7 quarters. The position peaked at $389K in Q4 2019. 203 funds tracked by Wall St. Rank hold SGMO as of Q1 2021.

  • Dupont Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
  • Dupont Capital Management sold 23,907 SANGAMO THERAPEUTICS INC shares in Q1 2021, an estimated $373K.
  • Dupont Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 7 quarters.
  • Dupont Capital Management's SANGAMO THERAPEUTICS INC position peaked at $389K in Q4 2019.
  • 203 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2021.

Based on Dupont Capital Management's 13F filing for Q1 2021, filed 29 Apr 2021.